FindTrial
Sign In

Efficacy of autologous adipose stromal vascular fraction in the treatment of knee osteoarthritis

Efficacy of autologous adipose stromal vascular fraction in the treatment of knee osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052818
Enrollment
Unknown
Registered
2021-11-05
Start date
2013-05-01
Completion date
Unknown
Last updated
2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

SVF group:stromal vascular fraction
HA group:hyaluronic acid

Sponsors

Zhejiang Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis met the diagnostic criteria in the American Rheumatism Association Revised Classification Criteria for Knee Osteoarthritis; 2. Kellgren-Lawrence (KL) grade 2 to 3; 3. Aged 20 to 85 years; 4. No history of significant trauma.

Exclusion criteria

Exclusion criteria: 1. Local infection of the knee joint; 2. Systemic diseases such as blood disorders or diabetes; 3. Rheumatoid arthritis, gout, autoimmune disease, or malignancy in the past 5 years; 4. Prior injection or use of oral steroids within 3 weeks before screening; 5. Knee surgery within 6 months before screening; 6. Pain attributed to displaced meniscal tear and torn ligaments.

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster Universities Osteoarthritis Index ;VAS score;MRI;X-Ray;—

Countries

China

Contacts

Public ContactMao Qiang

Zhejiang Provincial Hospital of Chinese Medicine

zyydxmq@126.com+86 15700151170

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026